Benzodiazepine withdrawal symptoms range from rebound anxiety and insomnia to seizures, delirium, and psychosis, and the severe end of that range is what sets this drug class apart. In 2020, the FDA wrote the risk into the boxed warning on every benzodiazepine: stopping abruptly or reducing the dosage too quickly “can result in withdrawal reactions, including seizures, which can be life-threatening” [1].
Physical dependence can develop whBenzodiazepine withdrawal symptoms range from rebound anxiety and insomnia to seizures, delirium, and psychosis, and the severe end of that range is what makes abrupt benzodiazepine discontinuation dangerous. In 2020, the FDA strengthened the boxed warning across the benzodiazepine class, stating that stopping suddenly or reducing the dose too quickly can cause withdrawal reactions, including life-threatening seizures [1]. Physical dependence can develop after benzodiazepines are taken steadily for several days to weeks, even at prescribed doses [1].
Anyone who has been taking a benzodiazepine regularly should talk with a healthcare professional before reducing or stopping it, and people who are physically dependent should not stop abruptly. Benzodiazepine addiction treatment in Minnesota begins with an individualized assessment and, when needed, a gradual taper rather than a sudden stop.
The key takeaways:
- A seizure, severe confusion, hallucinations, suicidal thoughts, or other severe symptoms during withdrawal require urgent medical evaluation.
- Withdrawal usually begins sooner with short-acting benzodiazepines and later with long-acting ones.
- Seizures, delirium, and psychosis are among the most serious complications, with greater risk after abrupt cessation, high doses, and short-acting drugs such as alprazolam.
- Acute withdrawal can last days to weeks, while some people develop protracted symptoms that continue for months.
Why Benzodiazepine Withdrawal Happens
Benzodiazepines enhance the effects of GABA, the main inhibitory neurotransmitter in the central nervous system [2]. With repeated use, the brain adapts through several changes involving GABA-A receptors and other excitatory and inhibitory systems. Those adaptations are complex and are not explained by simple receptor downregulation alone. Tolerance can develop to some benzodiazepine effects, while physical dependence means the nervous system has adapted enough that reducing or stopping the drug can produce withdrawal. The parent guide covers what benzodiazepines are and how they work.
When a physically dependent person reduces the medication too quickly, the balance shifts toward excessive nervous-system activity. That can produce anxiety, insomnia, tremor, sweating, palpitations, and other withdrawal symptoms. Severity depends on factors such as dose, duration of regular use, how quickly the dose is reduced, the drug’s half-life, previous withdrawal experiences, and individual medical factors. Short-acting drugs such as alprazolam can produce withdrawal sooner and sometimes more intensely than longer-acting drugs. The chapter on the strongest benzodiazepine explains potency, which is related to dose but is not the only factor that determines withdrawal severity.
Benzodiazepine Withdrawal Timeline: Short-Acting vs Long-Acting Benzodiazepines
When Symptoms Start
Withdrawal timing depends heavily on the benzodiazepine’s duration of action. With short-acting drugs, symptoms may begin within roughly one to two days after the last dose, while longer-acting benzodiazepines may not produce noticeable withdrawal for several days [3]. Alprazolam and other short-acting agents therefore tend to produce earlier withdrawal, and severe withdrawal is more strongly associated with short-acting drugs, particularly alprazolam [6].
Longer-acting medications such as diazepam leave the body more gradually, and diazepam also has long-lived active metabolites, which can delay and smooth the onset of withdrawal. That slower decline is one reason some tapering strategies consider a transition to a longer-acting medication for selected patients. Our chapter on the longest-lasting benzodiazepine compares the class by duration. Age, liver function, other medications, and individual metabolism can shift the timeline in either direction.
Acute Withdrawal
The acute phase, when symptoms are most intense, typically lasts several weeks. Early withdrawal brings anxiety, insomnia, and physical agitation; acute withdrawal symptoms often peak in the first one to two weeks and then ease. This is also the window for seizures, which have been reported from one to twelve days after discontinuation [4]. Benzodiazepine withdrawal duration tracks the drug’s exit from the body; see how long do benzodiazepines stay in your system.
Protracted Withdrawal Syndrome
Acute withdrawal does not always end cleanly. Ashton estimated that “a sizeable minority, perhaps 10% to 15%” of long-term users develop protracted withdrawal symptoms, a post-withdrawal syndrome that “may linger for months or even years” [5]. Sometimes called post-acute withdrawal syndrome, the protracted phase features persistent symptoms such as anxiety, insomnia, depression, tinnitus, tingling, and muscle pain, usually in waves. Prolonged withdrawal symptoms do improve: Ashton described the acute phase merging into a protracted phase in which protracted symptoms gradually decline, often taking six to twelve months to subside [5].
Benzodiazepine Withdrawal Symptoms
Clinical guidance sorts the benzodiazepine withdrawal syndrome into three clusters: anxiety-related symptoms, perceptual distortions, and major events [6].
Physical Symptoms
Physical symptoms commonly include tremor, sweating, rapid heartbeat, headache, muscle pain, muscle spasms or twitching, nausea, abdominal symptoms, appetite changes, sleep disturbance, and visual changes [3][4]. Paresthesia, tingling, burning or abnormal skin sensations, and heightened sensitivity to sensory input can also occur. Chest pain, severe palpitations, markedly abnormal blood pressure, or other concerning cardiovascular symptoms warrant prompt medical evaluation because they can overlap with more serious conditions.
Psychological and Cognitive Symptoms
Psychological symptoms center on rebound anxiety: the anxiety symptoms return stronger than before treatment, often with panic attacks even in people with no prior panic disorder. Irritability, restlessness, depression, and prolonged anxiety are common, and cognitive symptoms such as poor concentration and memory lapses can persist into the protracted phase as cognitive difficulties or measurable cognitive deficits [3, 5]. These mood changes are different from the Xanax side effects seen while taking the drug.
Perceptual Disturbances and Severe Symptoms
The third cluster sets benzo withdrawal apart from ordinary anxiety. Perceptual distortions include hypersensitivity to light, sound, and touch, abnormal body sensations, and depersonalization or derealization, the feeling of being detached from oneself or from reality [6]. The severe withdrawal symptoms are generalized seizures, delirium, and psychotic symptoms such as hallucinations and paranoia [3, 6]. These withdrawal phenomena occur in people with no psychiatric history.
Why Benzodiazepine Withdrawal Is Dangerous
Seizures are the reason. Abrupt cessation after as little as one to six months of use can cause life-threatening seizures [4], and a withdrawal seizure can happen to someone who has never had one, because removing the drug lowers the seizure threshold. Delirium and psychosis bring serious complications of their own: falls, dehydration, and actions taken while out of touch with reality. Other depressants, particularly alcohol, and opioids or sleep medications compound the danger. The interactions are covered in our chapter on lorazepam interactions here.
Certain factors make severe withdrawal more likely. Current clinical guidance identifies abrupt cessation, a short-acting medication, especially alprazolam, and higher doses as important predictors [6]. Longer duration of regular use, previous difficult withdrawals, a history of seizures, other substance use, and unstable medical or psychiatric conditions can also increase risk [4][6]. Tolerance can decrease after a period without a benzodiazepine, so restarting a previously tolerated amount or combining benzodiazepines with alcohol or opioids can create additional overdose risk. Our chapter on Xanax overdose explains why a familiar dose can become a fatal one.
When Benzodiazepine Withdrawal Becomes a Medical Emergency
Call 911 for a seizure, severe confusion or delirium, hallucinations or psychosis, trouble breathing, chest pain, a serious irregular heartbeat, severe agitation with fever, suicidal thoughts or behavior, or any rapidly worsening medical symptoms during withdrawal. Severe benzodiazepine withdrawal may need hospital treatment so clinicians can manage seizures, monitor vital signs, and treat other complications [1][6].
Alcohol should not be used to manage benzodiazepine withdrawal. It can add central nervous system depression while benzodiazepines are still present and can create additional risks, particularly for someone who also has alcohol dependence. Clinicians monitor withdrawal through symptoms and vital signs. Structured tools such as the CIWA-B exist, but current ASAM guidance notes that benzodiazepine-withdrawal scales have limited validation and are not used routinely in every setting [7].
Inpatient withdrawal management may be appropriate for people with seizure history, polydrug dependence, significant medical or psychiatric instability, or other factors that make outpatient management unsafe [6][7].
How Supervised Benzodiazepine Withdrawal Works
Safe benzodiazepine discontinuation is a gradual reduction, not a stop. The 2025 joint guideline from the American Society of Addiction Medicine and nine partner societies states that patients who have taken a benzodiazepine for longer than a month “should not abruptly discontinue the medication, but rather should gradually taper the dosage over a period of time under clinical supervision” [7].
Clinicians set the pace of dose reduction individually and slow it when symptoms flare. Clinicians often switch a short-acting drug for a longer-acting one to smooth the withdrawal process, and adjunctive medications can ease specific symptoms such as insomnia. Medical supervision also means treating what the benzodiazepine was covering. Anxiety disorders, panic disorder, and other mental health conditions need their own plan, through therapy and non-benzodiazepine medications.
Mental health services, support groups, and a treatment program that understands benzodiazepine dependence and the anxiety beneath it carry people through the months that follow. For a drug-specific walkthrough, see how to wean off lorazepam.
Frequently Asked Questions About Benzo Withdrawal
When Do Benzodiazepine Withdrawal Symptoms Peak?
Withdrawal usually begins and peaks sooner with short-acting benzodiazepines than with long-acting ones. For short-acting drugs, symptoms often become most intense during the first one to two weeks, while longer-acting drugs may peak later. Seizures, when they occur, have been reported one to twelve days after discontinuation [4]. A gradual, individualized taper can reduce the intensity and risks of withdrawal, but it does not guarantee that symptoms will be absent.
How Long Does Protracted Withdrawal Last?
Protracted withdrawal, sometimes called post-acute withdrawal syndrome, affects an estimated 10 to 15 percent of long-term users and can last months, occasionally years [5]. The FDA has documented cases lasting up to 12 months [1]. Symptoms come in waves and gradually decline; Ashton observed them taking six to twelve months to subside completely in many people.
Can Benzodiazepines Be Stopped Abruptly?
No. After regular use of more than a few weeks, abrupt cessation can cause seizures, delirium, and psychosis, and the FDA’s boxed warning describes these withdrawal reactions as potentially life-threatening [1]. The 2025 joint guideline advises that anyone who has taken a benzodiazepine for over a month taper under clinical supervision rather than stop [7].
Getting Help for Benzodiazepine Withdrawal in Minnesota
If you have been taking a benzodiazepine regularly and the idea of stopping worries you, do not make a sudden change on your own. A healthcare professional can assess your risk of withdrawal and determine whether a gradual taper is appropriate. Northwoods Haven’s intensive outpatient program provides treatment for substance use alongside anxiety, insomnia, trauma-related symptoms, and other mental health concerns on a schedule designed around work and family. Reach out for a confidential conversation about where to begin.
Sources
- U.S. Food and Drug Administration, “FDA Requiring Boxed Warning Updated to Improve Safe Use of Benzodiazepine Drug Class,” Drug Safety Communication, September 23, 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class
- Bounds CG, Patel P. “Benzodiazepines.” StatPearls, National Library of Medicine, updated January 30, 2024. https://www.ncbi.nlm.nih.gov/books/NBK470159/
- Mind, “Withdrawal Effects of Benzodiazepines,” published April 2021, last updated December 2024. https://www.mind.org.uk/information-support/drugs-and-treatments/sleeping-pills-and-minor-tranquillisers/withdrawal-effects-of-benzodiazepines/
- Brett J, Murnion B. “Management of Benzodiazepine Misuse and Dependence.” Australian Prescriber 2015;38(5):152-155. https://australianprescriber.tg.org.au/articles/management-of-benzodiazepine-misuse-and-dependence.html
- Ashton CH. “Protracted Withdrawal From Benzodiazepines: The Post-Withdrawal Syndrome.” Psychiatric Annals 1995;25(3):174-179. https://www.benzo.org.uk/pha-1
- SA Health (Government of South Australia), “Benzodiazepine Withdrawal Management,” clinical guideline, last updated April 3, 2026. https://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/clinical+resources/clinical+programs+and+practice+guidelines/substance+misuse+and+dependence/substance+withdrawal+management/benzodiazepine+withdrawal+management
- American Society of Addiction Medicine et al., “Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Benzodiazepine Risks Outweigh Benefits,” approved February 28, 2025. https://www.asam.org/quality-care/clinical-guidelines/benzodiazepine-tapering
